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S-I. Flow-through capture simulations 
 
The fraction of nucleic acid molecules captured in a membrane pore compared to the amount 
flowed through (capture efficiency) is a function of pore geometry, flow parameters, and 
adsorption kinetics (Figure S-1). The concentration of nucleic acids at any position in the pore, 
C(r, z), was simulated at steady-state using the Transport of Diluted Species module of Comsol 
Multiphysics (version 4.4) with the parameters listed in Table S-1. To generate the data for 
Figure 1b-c, a parametric sweep was performed with various values of kon·γ, U, Rp, and δm 
(Table S-2 and Table S-3). Then, the inlet flux (Jin = J|z = δm) and outlet flux (Jout = J|z = 0) were 
evaluated and used in Eq. S-1 to calculate capture efficiency. 
 𝐶𝐶𝐶𝐶𝐶𝐶𝐶 % = 1 − 𝐽𝑜𝑜𝑜
𝐽𝑖𝑖
 (S-1) 
 
Figure S-1. Schematic of flow-through simulation geometry.  Red represents the capture agent (γ) coated 
on the surface of the pore wall. 
Table S-1. Parameters used in the flow-through capture simulations. 
Parameter Description Value 
Rp Pore radius 0.56  – 17.78 μm 
δm Pore length (thickness of membrane) 0.316  – 3162 μm 
U Flow velocity 0.118 – 1000 mm/s 
D Diffusivity of nucleic acid molecule 10 μm2·s-1 
kon Nucleic acid binding rate constant 106 L·mol-1·s-1 
γ Surface concentration of capture agent 10-7 mol·m-2 
Cin Inlet concentration of nucleic acids 1 μM 
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Table S-2. The product of kon·γ was varied to generate Capture % as a function of Damköhler number 
(Da) (Figure 1b).  Rp (1 μm), δm (100 μm),U (2 mm/s), D (10 μm2·s-1), and Cin (1 μM) were held constant. 
kon·γ (m/s) kc (m/s) Da Jin (mol/s) Jout (mol/s) Capture % 
1.00E-07 1.62E-05 0.01 -3.92E-18 -3.88E-18 1.0 
2.15E-07 1.62E-05 0.01 -3.92E-18 -3.83E-18 2.1 
4.64E-07 1.62E-05 0.03 -3.92E-18 -3.74E-18 4.5 
1.00E-06 1.62E-05 0.06 -3.92E-18 -3.55E-18 9.3 
2.15E-06 1.62E-05 0.13 -3.92E-18 -3.19E-18 18.5 
4.64E-06 1.62E-05 0.29 -3.92E-18 -2.58E-18 34.2 
1.00E-05 1.62E-05 0.62 -3.92E-18 -1.75E-18 55.2 
2.15E-05 1.62E-05 1.33 -3.92E-18 -9.77E-19 75.0 
4.64E-05 1.62E-05 2.87 -3.92E-18 -5.03E-19 87.2 
1.00E-04 1.62E-05 6.17 -3.92E-18 -2.94E-19 92.5 
2.15E-04 1.62E-05 13.3 -3.92E-18 -2.11E-19 94.6 
4.64E-04 1.62E-05 28.7 -3.92E-18 -1.78E-19 95.5 
1.00E-03 1.62E-05 61.7 -3.92E-18 -1.63E-19 95.8 
2.15E-03 1.62E-05 133 -3.92E-18 -1.57E-19 96.0 
 
Table S-3. U, δm, or Rp was varied to generate Capture % as a function of Péclet number (Pe) (Figure 
1c).  Cin (1 μM), kon·γ (10-4 m/s), and D (10 μm2·s-1) were held constant. 
U (m/s) δm (μm) Rp (μm) Pe Jin (mol/s) Jout (mol/s) Capture % 
1.18E-04 100 1 0.12 -2.46E-19 -2.32E-36 100.0 
2.68E-04 100 1 0.27 -5.32E-19 -1.00E-26 100.0 
6.11E-04 100 1 0.61 -1.20E-18 -4.11E-22 100.0 
1.39E-03 100 1 1.39 -2.72E-18 -7.21E-20 97.4 
3.16E-03 100 1 3.16 -6.19E-18 -1.11E-18 82.0 
7.20E-03 100 1 7.20 -1.41E-17 -5.92E-18 58.0 
1.64E-02 100 1 16.4 -3.21E-17 -2.02E-17 37.0 
3.73E-02 100 1 37.3 -7.30E-17 -5.70E-17 22.0 
8.48E-02 100 1 84.8 -1.66E-16 -1.46E-16 12.3 
1.93E-01 100 1 193 -3.78E-16 -3.54E-16 6.5 
4.39E-01 100 1 439 -8.60E-16 -8.32E-16 3.2 
1.00E+00 100 1 1000 -1.96E-15 -1.93E-15 1.6 
2.00E-03 3162 1 0.06 -3.90E-18 8.30E-39 100.0 
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2.00E-03 1000 1 0.20 -3.90E-18 -1.15E-28 100.0 
2.00E-03 316 1 0.63 -3.90E-18 -1.72E-21 100.0 
2.00E-03 100 1 2.00 -3.90E-18 -2.90E-19 92.6 
2.00E-03 31.6 1 6.32 -3.90E-18 -1.50E-18 61.5 
2.00E-03 10.0 1 20.0 -3.90E-18 -2.65E-18 32.1 
2.00E-03 3.16 1 63.2 -3.90E-18 -3.30E-18 15.4 
2.00E-03 1.00 1 200 -3.90E-18 -3.65E-18 6.4 
2.00E-03 0.316 1 632 -3.90E-18 -3.80E-18 2.6 
2.00E-03 100 0.56 0.63 -1.23E-18 -1.60E-21 99.9 
2.00E-03 100 1.00 2.00 -3.90E-18 -2.90E-19 92.6 
2.00E-03 100 1.78 6.32 -1.23E-17 -4.20E-18 65.9 
2.00E-03 100 3.16 20.0 -3.90E-17 -2.30E-17 41.0 
2.00E-03 100 5.62 63.2 -1.23E-16 -9.40E-17 23.6 
2.00E-03 100 10.00 200 -3.90E-16 -3.40E-16 12.8 
2.00E-03 100 17.78 632 -1.23E-15 -1.15E-15 6.5 
 
Geometry: The model was assembled using a cylindrical geometry drawn in 2D axially 
symmetric space, with r as the radial component and z the axial component (Figure S-1).  The 
radius of the cylinder (Rp) varied from 0.56 μm to 17.78 μm; the length of the cylinder (δm) 
varied from 0.316 μm to 3162 μm (Table S-3). 
 
Transport: In a porous matrix, fluid flow can be approximated with a uniform velocity (U) 
independent of radius1.  The flow velocity varied from 1.18·10-4 m/s to 1 m/s (Table S-3).  The 
top boundary of the cylinder (z = δm) was an inlet and the bottom boundary (z = 0) was an outlet.  
The diffusion coefficient used was for DNA2, 10-11 m2/s. 
 
Kinetics:  The binding rate between nucleic acids and the capture agent was assumed to be 
second order with respect to nucleic acid concentration and capture agent surface concentration. 
We assumed the surface concentration of capture agent (γ) was in excess (and therefore 
unchanging during the course of the adsorption reaction) and estimated it to be 10-7 mol/m2.  
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With a kinetic rate constant estimated from nucleic acid-cationic polymer kinetics3, the 
adsorption rate occurring at the pore wall is shown in Eq. S-2. 
 𝑅𝑎𝑎𝑎 = 𝑘𝑜𝑖 ∙ 𝛾 ∙ 𝐶(𝑅𝑝, 𝑧) (S-2) 
Normally, adsorption kinetics include both an on and off rate.  However, in this situation, we 
excluded the off rate from analysis because it was insignificant compared to the on rate (kon ~ 107 
M-1s-1, koff ~ 10-3 s-1, reference 38 from the manuscript). 
 
Boundary conditions:  The inlet concentration of nucleic acid molecules (Cin = 10-6 mol/L) 
represents a normal nucleic acid concentration in human blood plasma4.  Axial symmetry was 
imposed at r = 0, and a flux boundary condition (Eq. S-3) was imposed at r = Rp to represent the 
adsorption of nucleic acid molecules to the surface of the pore wall. 
 𝑅𝑎𝑎𝑎  = 𝐷 𝜕𝐶(𝐶, 𝑧)𝜕𝐶 �𝑟=𝑅𝑝 (S-3) 
Mesh and solver settings: The geometry was meshed using a Free Triangular mesh with a 
maximum element size of 0.0525 𝜇m.  The Direct Stationary Solver (PARDISO) was used with 
a nested dissection multithreaded preordering algorithm and an auto scheduling method. 
 
S-II. Equation 3 and Figure 2b 
 
The number of pores in a membrane (np) can be calculated from the porosity (ϕ) as in Eq. S-4. 
 𝜙 = 𝑛𝑝𝜋𝑅𝑝2
𝜋𝑅𝑚2
→ 𝑛𝑝 = 𝜙𝑅𝑚2𝑅𝑝2  (S-4) 
The flow rate through the entire membrane (Q) is the flow rate through each pore (Qp) multiplied 
by the number of pores (Q = npQp).  Using Eq. S-4 for np and solving for Qp gives the following: 
 𝑄𝑝 = 𝑄𝑅𝑝2𝜙𝑅𝑚2  (S-5) 
Eq. S-6 results from plugging Eqn S-5 into the relationship between pore flow rate and flow 
velocity (Qp = UπRp2).                        𝑈 = 𝑄𝑝
𝜋𝑅𝑝2
= 𝑄
𝜋𝜙𝑅𝑚2
 (S-6) 
Then, using Eq. S-6 in Eq. 2 and setting the condition that Pe < 1 yields Eq. S-7.                              𝑃𝐶 = 𝑈𝑅𝑝2
𝐷𝛿𝑚
= 𝑄𝑅𝑝2
𝜋𝜙𝑅𝑚2 𝐷𝛿𝑚
< 1 (S-7) 
Solving Eq. S-7 for Q yields Eq. 3. ϕ = 0.6 and D = 10-11 m2/s were assumed for all calculations. 
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To calculate the pressure drop as a function of pore radius (Rp) and membrane radius (Rm), 
Pouiselle flow was assumed (Eq. S-8).  Flow rate through the pore (Qp) was replaced with flow 
rate through the entire membrane (Q) using Eq. S-5.  Q (1 mL/min), μ (10-3 Pa·s), and ϕ (0.6) 
were held constant; Rp and Rm were varied from 1 to 3 μm and 1 to 3 mm, respectively. The 
results, along with regimes of Pe < 1 calculated from Eq. 2, are plotted in Figure 2b. 
 Δ𝑃 = 8𝜇𝑄𝑝𝛿𝑚
𝜋𝑅𝑝4
= 8𝜇𝑄𝛿𝑚
𝜋𝜙𝑅𝑝2𝑅𝑚2
 (S-8) 
 
S-III. DNA binding efficiency as a function of Pe 
 
100 ng of salmon sperm DNA (Invitrogen, CA) in 200 μL of 10 mM MES buffer (pH ~5) was 
flushed through a chitosan membrane with a radius of 2 mm at different flow rates via the 
syringe/luer lock system shown in Figure S-4. The inlet and eluate DNA concentration of each 
flush was measured with PicoGreen dye (Invitrogen, CA); converting to mass (mDNA), Eq. S-9 
was then used to calculate the capture efficiency. 
𝐶𝐶𝐶𝐶𝐶𝐶𝐶 % = �1 −𝑚𝐷𝐷𝐷,𝑜𝑜𝑜
𝑚𝐷𝐷𝐷,𝑖𝑖 � · 100 (S-9) 
Pe was calculated via Eq. 2 and the results are plotted in Figure S-2.  This agrees with 
theoretical predictions that Pe > 1 results in reduced capture.  Also, layering the nylon membrane 
with chitosan does not significantly hinder flow rate or require untenable pressure drops to 
achieve flow rates of ~ 1 mL/min and efficient capture. 
 
Figure S-2. Capture efficiency depends on flow rate. 
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We clarify that capture efficiencies > 90% are only possible when the capture agent is in excess 
of the target DNA molecule and Pe < 1, which is the case for 100 ng of input DNA (Figure S-2). 
On the other hand, the purpose of the experiments in Figure 3 was to measure the total binding 
capacity of the chitosan membrane (i.e., occupy all the cationic binding sites). To accomplish 
this, larger quantities of DNA (1000 ng) were flowed through the membrane and the capture 
efficiency was not expected to be high; in fact, with each successive load, it should decrease to 
0% until all binding sites are occupied. Indeed, we observed that the capture efficiency in Figure 
3 varied from 60% in the first run to 20% in the fifth run—by the time the fifth load of 1000 ng 
DNA was flowed through the membrane, there were fewer binding sites available and thus the 
recovery was much lower than the first load when all binding sites were available. 
 
S-IV. Compatibility of chitosan membrane with in situ amplification 
 
To test the compatibility of chitosan membranes with in situ PCR amplification, 1 μL of varying 
concentrations of λ DNA was wetted into chitosan membrane with a radius of 2 mm.  The 
membrane was then placed in a well plate and 10 μL PCR mix was added to the well. Replicates 
containing 10 μL PCR mix with the same amount of λ DNA and no membrane present were also 
included.  The well plate was inserted into an Ilumina EcoTM real-time PCR System (EC-101-
1001) and thermal cycled; correct λ-phage DNA product was verified with melt curve analysis.  
The PCR mix and thermal cycling conditions used were the same as described in the 
Experimental Section.  Figure S-3a shows that chitosan membranes are compatible with in situ 
PCR amplification down to ~2 copies/reaction. 
 
To test compatibility with in situ LAMP amplification, 20 copies of λ DNA were wetted into a 
chitosan membrane with a radius of 2 mm.  The membrane was then placed in a well plate and 
10 μL LAMP mix was added to the well. Replicates containing 10 μL LAMP mix with 20 copies 
of λ DNA and no membrane present were also included as solution controls.  The well plate was 
inserted into an Ilumina EcoTM real-time PCR System and incubated for 40 min at 68 °C. Figure 
S-3b shows the real-time fluorescent traces representing DNA product. 
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Figure S-3.  Compatibility of chitosan membranes with PCR and LAMP amplification. a) Dilutions of λ 
DNA were wetted onto chitosan membranes or placed into a well plate without a membrane; PCR mix 
was added and amplification was detected via melt curve analysis.  Six replicates were run at each 
dilution; the percent of replicates positive for λ DNA product is shown (n = 6).  b) 20 copies of λ DNA 
were wetted onto chitosan membranes within a well plate, or placed into a well plate without a 
membrane; LAMP mix was added and amplification was detected via real-time fluorescence.  Three 
replicates were run for each sample; the fluorescent traces as a function of time are plotted. 
LAMP reagents were purchased from Eiken Chemical (Tokyo, Japan), product code LMP207.  
The LAMP mixture used for amplification of λ-phage DNA contained the following: 5 μL 
Reaction Mixture, 0.4 μL of Enyzme Mixture, 0.5 μL of 20X LAMP primer mixture (Table S-6), 
0.25 μL of Calcein (Fd), and 3.85 μL of nuclease-free water. 
 
S-V. Details of capture and in situ amplification (Figure 5) 
 
Figure S-4 is a schematic of the syringe/luer lock system used to flow mL-scale volumes 
through chitosan membranes with a radius of 2 mm. Syringes were purchased from BD (Franklin 
Lakes, NJ) and luer locks (Catalog #LC78-J1A) were purchased from Nordson Medical 
(Westlake, Ohio). Table S-4 shows all the quantities of λ DNA, volumes of 10 mM MES buffer, 
and amounts of background DNA used to generate Figure 5a. Salmon sperm DNA from 
Invitrogen (Carlsbad, CA) was used as “background DNA”. 
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Figure S-4.  Schematic of syringe/luer lock system used to flow mL-scale volumes through the chitosan 
membrane with a radius of 2 mm.  A chitosan membrane is placed in between two luer locks.  A syringe 
containing a nucleic acid sample is connected to the top luer lock and the plunger is compressed to flush 
the sample through the membrane.  Then, the luer locks are disconnected from the syringe, taken apart, 
and the membrane containing captured nucleic acids is placed in a PCR tube along with amplification mix 
for thermal cycling. 
Table S-4. Volumes of 10 mM MES (2-(N-morpholino)ethanesulfonic acid) buffer and final 
concentrations of λ DNA used for Figure 5a.  The two fabrication methods are described in the 
Experimental Section. 
Copies of λ 
DNA 
Volume of 
10 mM 
MES buffer 
(mL) 
λ DNA 
Concentration 
(cop/mL) 
Background 
DNA added to 
MES buffer (ng) 
Positive 
membranes 
Total 
membranes 
tested 
Fabrication 
Method 
0 1 0 100 0 3 A 
0 3 0 100 0 3 B 
10 50 0.2 100 1 1 B 
10 50 0.2 100 1 4 A 
5 15 0.3 100 2 2 A 
10 30 0.3 100 1 2 A 
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10 25 0.4 100 1 2 A 
5 10 0.5 100 2 2 A 
10 20 0.5 100 3 4 A 
25 50 0.5 100 1 1 B 
25 50 0.5 0 1 1 B 
9 10 0.9 10 6 6 B 
5 5 1.0 100 2 2 A 
10 10 1.0 100 1 2 A 
10 10 1.0 50 3 3 B 
9 5 1.8 0 6 6 B 
6 3 2.0 100 2 3 B 
10 5 2.0 50 2 3 B 
12 5 2.4 100 3 3 A 
10 4 2.5 100 2 2 A 
5 1 5.0 100 5 5 A 
10 2 5.0 100 4 4 A 
6 1 6.0 100 3 3 B 
10 1 10.0 100 3 4 A 
20 2 10.0 100 2 2 A 
10 1 10.0 0 2 3 B 
20 1 20.0 100 5 5 A 
20 1 20.0 0 3 3 B 
 
To detect λ DNA product after in situ amplification, two methods were used.  i) After thermal 
cycling the membrane with PCR mix in a well plate, an appropriate amount of 6x gel loading dye 
and TE buffer was added to each well and pipette mixed.  Then, 5 μL of this solution was 
removed from the well, placed in a 1.2% agarose gel, and run for 50 min at 80V.  Samples with 
DNA product at the same length as the λ PCR amplicon (322 base pairs) were considered 
positive.  An example of a gel image is shown in Figure S-5a. ii) After thermal cycling, the PCR 
reaction mixture was transferred to an empty well and an appropriate amount of 20X Evagreen 
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dye (Biotium) and 10X TE buffer was added. A continuous melt curve was then obtained from 
65–95 ˚C; samples with a peak around ~85 ˚C (the melting temperature of the λ PCR amplicon) 
were considered positive. (Figure S-5b). 
 
Figure S-5.  DNA detection after in situ amplification.  a) Varying concentrations of λ DNA in 10 mM 
MES buffer were flowed through chitosan membranes.  The membranes were then placed in a well plate 
and thermal cycled.  After thermal cycling, each sample was run on a gel. Lanes 1–2: 5 copies/mL; Lanes 
3–4: 2.5 copies/mL; Lane 5: positive control (10 copies of λ DNA in PCR mix, no membrane); Lane 6: 
negative control (0 copies of λ DNA in PCR mix, no membrane).  b) Dilutions of λ DNA were wetted 
onto chitosan membranes; PCR mix was added and melt curve fluorescent traces are plotted. Three 
replicates were run at each dilution. 
It is important to note that while Table S-4 includes experiments done on multiple batches of 
membranes over 8 months, it does not include all experiments that we performed with chitosan-
coated nylon membranes. Using binding capacity measurements (described in Experimental 
Section) and DNA capture experiments (described in S-V), we determined that there was batch-
to-batch variation in the fabrication process.  Therefore, only those batches with consistent 
performance were analyzed and other batches that did not meet our standards were excluded 
from analysis. 
 
Table S-5 summarizes Table S-4 by binning the various experiments into concentration ranges 
and reporting a “% Positive membranes” along with the standard error. This data is then plotted 
in Figure 5a of the manuscript. 
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Table S-5. Histogram of Table S-4 with concentration bins and standard error. 
Concentration 
(cop/mL) positive total positive/total SE 
0 0 6 0.00 0.00 
0.2 - 0.5 5 10 0.50 0.16 
0.5 - 0.9 6 7 0.86 0.13 
0.9 -  2.0 22 25 0.88 0.06 
2.0 - 10.0 24 26 0.92 0.05 
10.0 - 20.0 8 8 1.00 0.00 
 
To reliably detect ultra-low concentrations of nucleic acids from large volumes, we reduced the 
background DNA amount to 10 ng and relaxed the constraint imposed on the experiments for 
Figure 5a that the solution be flowed through the membrane at 1 mL/min. We instead flowed 
through at ~0.3 mL/min and compared 50 mL solutions with 100 ng background DNA to 50 mL 
solutions with 10 ng background DNA. These experiments showed that 25 copies in 50 mL can 
be consistently detected when the flow rate and background DNA are reduced from the previous 
constraints of 1 mL/min and 100 ng. The data is shown in Table S-6 below and summarized in 
the manuscript with Figure 5b. 
Table S-6. Volumes of 10 mM MES (2-(N-morpholino)ethanesulfonic acid) buffer and final 
concentrations of λ DNA used for Figure 5b.  The two fabrication methods are described in the 
Experimental Section. 
Copies of λ 
DNA 
Volume of 
10 mM 
MES buffer 
(mL) 
λ DNA 
Concentration 
(cop/mL) 
Background 
DNA added to 
MES buffer (ng) 
Positive 
membranes 
Total 
membranes 
tested 
Fabrication 
Method 
25 50 0.5 100 6 10 B 
25 50 0.5 10 9 9 B 
 
 
S-VI. Primer sequences for 𝝀-phage DNA PCR amplification and 𝝀-phage 
DNA LAMP amplification 
 
A mixture of primers from Table S-7 was made at 5 μM each in nuclease-free water and used for 
the PCR amplification reactions described in this manuscript. 
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Table S-7. Sequences for λ-phage DNA PCR primers. 
forward CGTTGCAGCAATATCTGGGC 
reverse TATTTTGCATCGAGCGCAGC 
 
A mixture of each primer from Table S-8 was made in nuclease-free water and used for the 
LAMP amplification reactions described in S-IV.  The concentration of each primer in the 20X 
mixture is also listed. 
Table S-8.  Sequences for λ-phage DNA LAMP primers5 and their concentration in the 20X primer mix. 
Name Sequence Conc. 
FOP GGCTTGGCTCTGCTAACACGTT 4 μM 
BOP GGACGTTTGTAATGTCCGCTCC 4 μM 
FIP CAGCCAGCCGCAGCACGTTCGCTCATAGGAGATATGGTAGAGCCGC 32 μM 
BIP GAGAGAATTTGTACCACCTCCCACCGGGCACATAGCAGTCCTAGGGACAGT 32 μM 
LOOPF CTGCATACGACGTGTCT 8 μM 
LOOPR ACCATCTATGACTGTACGCC 8 μM 
 
 
S-VII. CDI functionalization of nylon membrane 
 
Before coating with chitosan, the LoProdyne membrane was functionalized with N,N 
carbonyldiimidazole (CDI) in methylene chloride according to the manufacturer’s protocol.  The 
protocol is found at this website (http://www.pall.com/main/oem-materials-and-
devices/literature-library-details.page?id=4765) and is also copied below: 
 
LoProdyne LP membrane has hydroxyl surface chemistry. The membrane binds very little 
protein in standard binding tests using IgG or BSA. The membrane can be activated for 
covalent attachment using N, N® carbonyldiimidazole (CDI) in methylene chloride as 
follows:  
1. Dissolve 0.49 g CDI in 45 mL MeCl2.  
2. Add to a glass dish under a fume hood.  
3. Immerse sheet of LoProdyne LP membrane in this solution for 15 minutes, RT.  
4. Wash membrane 4X with 40 mL per wash MeCl2, 5 minutes per wash.  
5. Air dry at 60 °C for 3 minutes. 
6. Store in vacuum desiccator until use. 
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S-VIII. Complex solutions 
 
To test whether salts in solution could interfere with electrostatic binding and decrease the ability 
of chitosan membranes to capture and detect nucleic acids, we performed preliminary 
experiments in complex solutions. Ringer’s solution was used to mimic the salt concentration of 
plasma and was made according to the instructions at the following website: 
http://cshprotocols.cshlp.org/content/2008/1/pdb.rec11273.full?text_only=true. The information 
from the website is also pasted below: 
 
Ringer’s solution (pH 7.3-7.4) 
Reagent (amount to add): NaCl (7.2 gm), CaCl2 (0.17 gm), KCl (0.37 gm). 
Dissolve all reagents into reagent-grade H2O, and bring the final volume to 1 L. Adjust the pH to 
7.3-7.4. Once thoroughly dissolved, filter through a 0.22-μm filter, aliquot into single-use 
volumes (25-50 mL), and autoclave. 
 
The final salt concentration of the Ringer’s solution is ~125 mM.  5 mM EDTA was also tested 
because plasma is often processed and stored in an anticoagulant such as EDTA. 
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